Nasdaq-listed NewGenIvf Group Purchases 13,000.23 SOL and Joins $100M Gold-Backed Asset Tokenization; Reports $17.5M Q3 Profit and Approves 24-Month, $2M Stock Buyback

As of November 28, Nasdaq-listed NewGenIvf Group Limited reported in its latest financial filing that it had acquired approximately 13,000.23 SOL tokens and joined a notable gold-backed asset tokenization initiative valued at about $100 million, signaling expanding exposure to crypto assets within a regulated framework.

The report also indicates a Q3 net profit of $17.5 million, reflecting stronger operating performance and prudent expense controls in a volatile macro environment.

Additionally, the board approved a 24-month stock repurchase plan valued at $2 million, a move that signals capital-return discipline and confidence in the group’s intermediate-term trajectory.